Reply – Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Reply – Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Clin Gastroenterol Hepatol. 2019 Nov 12;:

Authors: Bergquist A, Stokkeland K, Bottai M, Söderberg-Löfdal K

PMID: 31730911 [PubMed – as supplied by publisher]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31730911?dopt=Abstract